Index by author

August 1, 2024; Volume 65,Issue 8

  1. Bourbonne, Vincent

    1. Diagnostic Performance of <sup>18</sup>F-FDG PET/CT According to Delay After Treatment to Detect Subclinical Recurrence of Head and Neck Squamous Cell Carcinoma
      Diagnostic Performance of 18F-FDG PET/CT According to Delay After Treatment to Detect Subclinical Recurrence of Head and Neck Squamous Cell Carcinoma
      Camille Clement, Jean-Christophe Leclère, Clémentine Maheo, Romain Le Pennec, Gregoire Le Gal, Olivier Delcroix, Philippe Robin, Jean Rousset, Valentin Tissot, Aziliz Gueguen, Maryne Allio, Vincent Bourbonne, Ulrike Schick, Remi Marianowski, Pierre-Yves Salaun and Ronan Abgral
      Journal of Nuclear Medicine August 1, 2024, 65 (8) 1181-1187; DOI: https://doi.org/10.2967/jnumed.124.267391

  2. Boursier, Caroline

    1. Factors Associated with Myocardial Uptake on Oncologic Somatostatin PET Investigations and Differentiation from Myocardial Uptake of Acute Myocarditis
      Factors Associated with Myocardial Uptake on Oncologic Somatostatin PET Investigations and Differentiation from Myocardial Uptake of Acute Myocarditis
      Thomas Larive, Caroline Boursier, Marine Claudin, Jeanne Varlot, Laura Filippetti, Olivier Huttin, Véronique Roch, Laetitia Imbert, Matthieu Doyen, Aurélien Lambert, Damien Mandry, Zohra Lamiral, Elodie Chevalier and Pierre-Yves Marie
      Journal of Nuclear Medicine August 1, 2024, 65 (8) 1279-1285; DOI: https://doi.org/10.2967/jnumed.123.267219

  3. Bowen, Emily Renee

    1. Design of a Fibroblast Activation Protein–Targeted Radiopharmaceutical Therapy with High Tumor–to–Healthy-Tissue Ratios
      Design of a Fibroblast Activation Protein–Targeted Radiopharmaceutical Therapy with High Tumor–to–Healthy-Tissue Ratios
      Ramesh Mukkamala, Daniel J. Carlson, Nicholas Kaine Miller, Spencer D. Lindeman, Emily Renee Bowen, Pooja Tudi, Taylor Schleinkofer, Owen C. Booth, Abigail Cox, Madduri Srinivasarao and Philip S. Low
      Journal of Nuclear Medicine August 1, 2024, 65 (8) 1257-1263; DOI: https://doi.org/10.2967/jnumed.124.267756

  4. Braren, Rickmer

    1. Spleen Volume Reduction Is a Reliable and Independent Biomarker for Long-Term Risk of Leukopenia Development in Peptide Receptor Radionuclide Therapy
      Spleen Volume Reduction Is a Reliable and Independent Biomarker for Long-Term Risk of Leukopenia Development in Peptide Receptor Radionuclide Therapy
      Lisa Steinhelfer, Friederike Jungmann, Lukas Endrös, Patrick Wenzel, Bernhard Haller, Manuel Nickel, Eva Haneder, Fabian Geisler, Katharina Götze, Alexander von Werder, Matthias Eiber, Markus R. Makowski, Rickmer Braren and Fabian Lohöfer
      Journal of Nuclear Medicine August 1, 2024, 65 (8) 1244-1249; DOI: https://doi.org/10.2967/jnumed.123.267098

  5. Brok, Jesper

    1. Performing [<sup>18</sup>F]MFBG Long–Axial-Field-of-View PET/CT Without Sedation or General Anesthesia for Imaging of Children with Neuroblastoma
      Open Access
      Performing [18F]MFBG Long–Axial-Field-of-View PET/CT Without Sedation or General Anesthesia for Imaging of Children with Neuroblastoma
      Lise Borgwardt, Jesper Brok, Kim Francis Andersen, Jacob Madsen, Nicholas Gillings, Marie Øbro Fosbøl, Charlotte Lund Denholt, Ida Nymann Petersen, Louise Sørup Sørensen, Lotte Hahn Enevoldsen, Peter Sandor Oturai, Helle Hjort Johannesen, Liselotte Højgaard, Christina Schulze, Eunice Saxtoft, Flemming Andersen and Barbara Malene Fischer
      Journal of Nuclear Medicine August 1, 2024, 65 (8) 1286-1292; DOI: https://doi.org/10.2967/jnumed.123.267256

  6. Brosch-lenz, Julia

    1. Impact of the Reference Multiple-Time-Point Dosimetry Protocol on the Validity of Single-Time-Point Dosimetry for [<sup>177</sup>Lu]Lu-PSMA-I&amp;T Therapy
      Open Access
      Impact of the Reference Multiple-Time-Point Dosimetry Protocol on the Validity of Single-Time-Point Dosimetry for [177Lu]Lu-PSMA-I&T Therapy
      Sandra Resch, Sibylle I. Ziegler, Gabriel Sheikh, Lena M. Unterrainer, Mathias J. Zacherl, Peter Bartenstein, Guido Böning, Julia Brosch-Lenz and Astrid Delker
      Journal of Nuclear Medicine August 1, 2024, 65 (8) 1272-1278; DOI: https://doi.org/10.2967/jnumed.123.266871
    2. An International Study of Factors Affecting Variability of Dosimetry Calculations, Part 3: Contribution from Calculating Absorbed Dose from Time-Integrated Activity
      Open Access
      An International Study of Factors Affecting Variability of Dosimetry Calculations, Part 3: Contribution from Calculating Absorbed Dose from Time-Integrated Activity
      Julia Brosch-Lenz, Sara Kurkowska, Eric Frey, Yuni K. Dewaraja, John Sunderland and Carlos Uribe
      Journal of Nuclear Medicine August 1, 2024, 65 (8) 1166-1172; DOI: https://doi.org/10.2967/jnumed.123.267293

  7. Buchalet, Chloé

    1. Prognostic Value of <sup>18</sup>F-FDG PET/CT Assessment After Radiotherapy of Squamous Cell Carcinoma of the Anus in Patients from the National Multicentric Cohort FFCD-ANABASE
      Prognostic Value of 18F-FDG PET/CT Assessment After Radiotherapy of Squamous Cell Carcinoma of the Anus in Patients from the National Multicentric Cohort FFCD-ANABASE
      Virginie Combet-Curt, Chloé Buchalet, Karine Le Malicot, Claire Lemanski, Emmanuel Deshayes, Nathalie Bonichon-Lamichhane, Astrid Lièvre, Florence Huguet, Ghoufrane Tlili and Véronique Vendrely
      Journal of Nuclear Medicine August 1, 2024, 65 (8) 1194-1201; DOI: https://doi.org/10.2967/jnumed.124.267626

  8. Buckle, Tessa

    1. <em>h</em>HEPATO-Cy5, a Bimodal Tracer for Image-Guided Hepatobiliary Surgery
      hHEPATO-Cy5, a Bimodal Tracer for Image-Guided Hepatobiliary Surgery
      Daphne D.D. Rietbergen, Tessa Buckle, Leon J. Slof, Maarten P. van Meerbeek, Clarize M. de Korne, Mick M. Welling, Matthias N. van Oosterom, Kevin Bauwens, Meta Roestenberg, Julia Kloetzl and Fijs W.B. van Leeuwen
      Journal of Nuclear Medicine August 1, 2024, 65 (8) 1301-1306; DOI: https://doi.org/10.2967/jnumed.123.266715

  9. Buteau, James P.

    1. Clinical Trial Protocol for VIOLET: A Single-Center, Phase I/II Trial Evaluation of Radioligand Treatment in Patients with Metastatic Castration-Resistant Prostate Cancer with [<sup>161</sup>Tb]Tb-PSMA-I&amp;T
      Clinical Trial Protocol for VIOLET: A Single-Center, Phase I/II Trial Evaluation of Radioligand Treatment in Patients with Metastatic Castration-Resistant Prostate Cancer with [161Tb]Tb-PSMA-I&T
      James P. Buteau, Louise Kostos, Ramin Alipour, Price Jackson, Lachlan McInstosh, Brittany Emmerson, Mohammad B. Haskali, Jing Xie, Elizabeth Medhurst, Rajeev Ravi, Brian D. Gonzalez, Heidi Fettke, Benjamin Blyth, Luc Furic, Katie Owen, Shahneen Sandhu, Declan G. Murphy, Arun A. Azad and Michael S. Hofman
      Journal of Nuclear Medicine August 1, 2024, 65 (8) 1231-1238; DOI: https://doi.org/10.2967/jnumed.124.267650

  10. Buvat, Irène

    1. RadShap: An Explanation Tool for Highlighting the Contributions of Multiple Regions of Interest to the Prediction of Radiomic Models
      Open Access
      RadShap: An Explanation Tool for Highlighting the Contributions of Multiple Regions of Interest to the Prediction of Radiomic Models
      Nicolas Captier, Fanny Orlhac, Narinée Hovhannisyan-Baghdasarian, Marie Luporsi, Nicolas Girard and Irène Buvat
      Journal of Nuclear Medicine August 1, 2024, 65 (8) 1307-1312; DOI: https://doi.org/10.2967/jnumed.124.267434
« Previous (Pages : 1 2 3 ... 3)next »
Back to top

In this issue